MedTrace Logo

Retinal Vascular Reactivity in Subjects With Newly Diagnosed Glaucoma Before and After Selective Laser Trabeculoplasty

NCT01209975 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2010-09-28

No results posted yet for this study

Summary

The purpose of this study is to assess retinal blood flow and vascular reactivity in patients with newly diagnosed primary open angle glaucoma pre- and post-primary Selective Laser Trabeculoplasty(SLT). Canon Laser Blood Flowmeter will be used for the assessment of retinal blood flow.

Conditions

Interventions

PROCEDURE

Selective Laser Trabeculoplasty

Patient will have selective laser trabeculoplasty as the first treatment for glaucoma. This treatment will be dictated clinically, since we do not assign the interventions.

Sponsors & Collaborators

  • University of Western Ontario, Canada

    collaborator OTHER

  • University of Toronto

    lead OTHER

Principal Investigators

  • Chris Hudson, PhD · University of Toronto

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01209975 on ClinicalTrials.gov